Assets of RayzeBio, Inc. from 31 Dec 2022 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
RayzeBio, Inc. quarterly Assets in USD history and change rate from 31 Dec 2022 to 30 Sep 2023.
  • RayzeBio, Inc. Assets for the quarter ending 30 Sep 2023 was $603,513,000.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)

RayzeBio, Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $603,513,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q4 2022 $324,776,000 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.